|
Ranbaxy
opens third R&D facility at Gurgaon
The President of India, Dr APJ Abdul Kalam recently inaugarated
the third drug discovery research centre of Ranbaxy Laboratories
(RL) at Gurgaon.
Glenmark
launches Stronat-a breakthrough in Osteoporosis management
Glenmark Pharmaceuticals, announced the launch of Strontium Ranelate
molecule for osteoporosis management. Glenmark is the first company
to launch this molecule in India which offers a breakthrough treatment
for osteoporosis.
Serum
launches combination vaccine for DTP and Hepatitis B
Serum Institute of India (SII), one of India’s largest vaccine
manufacturer, has announced the launch of its combination vaccine
Q-Vac for Diphtheria, Tetanus, Pertussis (DTP) and Hepatitis B.
Snap
Shot
Copycat
of Liptor threatens Pfizer’s profits
The decision that threatens Pfizer’s economic future could
be just weeks or months away. And the investors are waiting for
a federal court to decide whether a copycat form of Pfizer’s
$10 billion-a- year Lipitor cholesterol drug can come to market.
|
